Tirzepatide
Dual GIP / GLP-1 receptor agonist research peptide studied for metabolic physiology.
Tirzepatide is a dual glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptor agonist. It is investigated in research circles for metabolic regulation and is supplied as a high-purity lyophilized peptide.
Ingredients
Tirzepatide (≥98% purity by HPLC). 10 mg lyophilized peptide per vial. No non-active ingredients.
Directions
For research use only. Reconstitute per study protocol with bacteriostatic or sterile water. Store lyophilized at 2–8°C and away from light.
Warnings
NOT FOR HUMAN OR ANIMAL CONSUMPTION. Laboratory research use only. Not approved for human use by the FDA or Health Canada. Not designed to diagnose, treat, cure, or prevent any disease.
Shipping Information
- • Dispatched within 24 hours on business days
- • Discreet, temperature-aware packaging
- • Tracking provided on every shipment
- • Free shipping on orders over $150
Specifications
Customer Reviews
Reliable supplier, strong reconstitution characteristics, no residue.
Great for our continuing research protocols. COA matched expectations.
Arrived fast and well packaged. Lyophilization looked clean with a stable cake.
Excellent purity and consistent third-party results across multiple batches.
Satisfied with the product and documentation provided.
Related Products
Semaglutide
GLP-1 receptor agonist research peptide studied for appetite regulation and metabolic health.
Retatrutide
Triple receptor (GIP / GLP-1 / glucagon) agonist research peptide for metabolic studies.
Tesamorelin
Stabilised GHRH analog studied for visceral adipose tissue and metabolic research.